Activaero Raises €10.7 Million
Activaero GmbH, a German developer of controlled breathing devices for inhaled therapeutic agents, has raised €10.7 million in Series A funding. BioMedPartners led the round, and was joined by VI Partners, Abalis Finance AG and Vesalius Biocapital. MedVenture Partners served as placement agent.
29 October 2009•4 mins read
